The number of mergers and acquisitions in the pharmaceutical sector rose by 9% in the first half of this year, although the aggregate value fell in the absence of a &quotmega-merger&quot, according to new figures from PricewaterhouseCoopers.

There were 165 deals announced in the first half, compared with 152 in the same period last year, PwC said in its interim report on the sector.